Iovance Biotherapeutics, Inc. (IOVA)
14.62
+1.31
(+9.84%)
USD |
NASDAQ |
Oct 09, 16:00
14.62
0.00 (0.00%)
Pre-Market: 20:00
Iovance Biotherapeutics Free Cash Flow : -296.40M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -296.40M |
| March 31, 2026 | -305.02M |
| December 31, 2025 | -336.24M |
| September 30, 2025 | -351.82M |
| June 30, 2025 | -323.54M |
| March 31, 2025 | -347.50M |
| December 31, 2024 | -364.05M |
| September 30, 2024 | -374.08M |
| June 30, 2024 | -400.48M |
| March 31, 2024 | -405.08M |
| December 31, 2023 | -384.11M |
| September 30, 2023 | -377.30M |
| June 30, 2023 | -354.68M |
| March 31, 2023 | -333.42M |
| December 31, 2022 | -313.18M |
| September 30, 2022 | -293.91M |
| June 30, 2022 | -296.25M |
| March 31, 2022 | -277.66M |
| December 31, 2021 | -265.52M |
| September 30, 2021 | -290.12M |
| June 30, 2021 | -281.11M |
| March 31, 2021 | -259.09M |
| December 31, 2020 | -251.92M |
| September 30, 2020 | -223.15M |
| June 30, 2020 | -208.20M |
| Date | Value |
|---|---|
| March 31, 2020 | -201.82M |
| December 31, 2019 | -165.81M |
| September 30, 2019 | -140.40M |
| June 30, 2019 | -125.38M |
| March 31, 2019 | -114.49M |
| December 31, 2018 | -102.45M |
| September 30, 2018 | -91.51M |
| June 30, 2018 | -84.83M |
| March 31, 2018 | -78.01M |
| December 31, 2017 | -79.74M |
| September 30, 2017 | -71.73M |
| June 30, 2017 | -62.96M |
| March 31, 2017 | -49.24M |
| December 31, 2016 | -34.19M |
| September 30, 2016 | -28.02M |
| June 30, 2016 | -19.00M |
| March 31, 2016 | -19.84M |
| December 31, 2015 | -19.52M |
| September 30, 2015 | -17.53M |
| June 30, 2015 | -15.51M |
| March 31, 2015 | -12.20M |
| December 31, 2014 | -10.23M |
| September 30, 2014 | -7.738M |
| June 30, 2014 | -6.288M |
| March 31, 2014 | -5.646M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| AVITA Medical, Inc. | -25.21M |
| Halozyme Therapeutics, Inc. | 806.22M |
| Amgen, Inc. | 10.18B |
| CareDx, Inc. | 84.03M |
| Xencor, Inc. | -208.28M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -60.84M |
| Cash from Investing (Quarterly) | -74.05M |
| Cash from Financing (Quarterly) | 49.29M |
| Free Cash Flow Per Share (Quarterly) | -0.1472 |
| Free Cash Flow to Equity (Quarterly) | -64.51M |
| Free Cash Flow to Firm (Quarterly) | -66.28M |
| Free Cash Flow Yield | -4.95% |